Clinical Trials Sponsored by Ina-Respond

Total 36576 results

Ina-Respond

Recruiting

Observational Research on Infectious Disease Outbreaks and Difficult Cases of Unidentified Etiology in Indonesia (INA-ORCHID)

Infectious Disease

Indonesia
Ina-Respond

Completed

Evaluation of GeneXpert HIV-1 as The Gold Standard Test for HIV-1 Viral Load Count (ProXpert)

HIV

Indonesia
INA-RESPOND Secretariat
United States Agency for International Development (USAID); Indonesia Research...

Completed

Implementing a Combination of Clinical Parameters (Rapid Diagnostic Tests (RDTs), Biomarkers and SoCs for the Etiology Diagnoses of Pneumonia in Pediatric Patients to Improve Clinical Management in Indonesia. (PEER-PePPes)

Pneumonia

Indonesia
Immune Response BioPharma, Inc.

Not yet recruiting

A Study of NeuroVax™, a Novel Therapeutic TCR Peptide Vaccine for Pediatric Multiple Sclerosis

Multiple Sclerosis

United States
Immune Response BioPharma, Inc.

Unknown

REMUNE HIV/AIDS Vaccine Phase II Pediatric Safety & Efficacy Clinical Study

HIV/AIDS

United States
Ina-Respond
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

HIV Infection and Risk Related Coinfections/Comorbidities in Indonesia (INAPROACTIVE)

HIV

Indonesia
Response Pharmaceuticals

Completed

Effect of RDX-002 on Postprandial Triglycerides in Subjects Treated With Olanzapine

Drug-induced Weight Gain

United States
Response Pharmaceuticals

Completed

Study of KD026 in Combination With Metformin in Subjects With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

United States
Immune Response BioPharma, Inc.

Unknown

REMUNE + AMPLIVAX IR103 HIV/AIDS Phase III Safety & Efficacy Study (RAISE)

HIV

United States
Immune Response BioPharma, Inc.
cro

Unknown

A Study of NeuroVax™, a Novel Therapeutic TCR Peptide Vaccine for SPMS of Multiple Sclerosis

Multiple Sclerosis

United States
Response Pharmaceuticals

Completed

Safety, Tolerability, and Pharmacodynamic Profile of Oral 2101 in Secondary Raynaud's Disease

Raynaud's Disease

Germany
Immune Response BioPharma, Inc.
cro

Recruiting

A Study of NeuroVax™, a Therapeutic TCR Peptide Vaccine for SPMS of Multiple Sclerosis

Multiple Sclerosis | Secondary Progress Multiple Sclerosis

United States
Response Biomedical Corp.

Completed

FLU A+B Nasal Swab Clinical Study (FLUA+B)

Influenza

United States, Canada
Response Biomedical Corp.

Completed

RAMP 200 / RAMP Cardiovascular Tests at the Point-of-Care (C-POC)

Myocardial Infarction | Heart Failure | Acute Coronary Syndrome | Congestive Heart Failure

United States
Response Pharmaceuticals

Completed

Safety and Effect of Oral Doses of 5mg or 10mg of SLx-2101 for 14 Days in Patients With Hypertension

Hypertension

Germany
Response Pharmaceuticals

Completed

A Comparison of SLx-4090 in Combination With Metformin Versus Metformin Therapy Alone in Patients With Type 2 Diabetes

Type 2 Diabetes

United States
Response Pharmaceuticals

Completed

Comparison of SLx-4090 Combined With Statin Therapy Versus Statin Alone in Reducing LDL-C in Patients With Hyperlipidemia

Hyperlipidemia

United States
Response Pharmaceuticals

Completed

Evaluation of Safety and Effects of SLx-4090 After Dosing for 14 Days in Subjects With High Triglycerides

Hypertriglyceridemia

Germany
Response Pharmaceuticals

Completed

Safety and Effects of SLx-2101 Taken for up to 14 Days on Blood Pressure in Patients With Hypertension

Hypertension

United Kingdom
Response Biomedical Corp.

Terminated

Beta-hCG Test Reference Range Determination

Healthy

Canada
Response Biomedical Corp.

Completed

Procalcitonin Test Reference Range Determination (PRO-H)

Healthy

Canada
Ina-Respond
National Institute of Health Research and Development, Ministry of Health...

Completed

Integration of Mental Health in HIV Clinic to Increase the Success of ARV Treatment in PLWHA in Hospitals

Depression | HIV/AIDS

Indonesia
Irish Response t/a Lifes2good
Stephens & Associates, Inc.

Completed

To Evaluate the Effects of Viviscal Oral Supplements When Used by Females With Self-perceived Thinning Hair

Hair Thinning

United States
Desmond Tutu HIV Centre

Unknown

A Study to Evaluate the Acceptability and Preference for Contraceptive Options as Proxy for HIV Prevention Methods (UChoose)

HIV

South Africa
University College, London
GN Resound

Completed

Effects of Remote Microphone Hearing Aids on Children With Auditory Processing Disorder

Auditory Processing Disorder
University of Iowa
GN Resound

Terminated

The Effect of Low-Level Laser Stimulation on Hearing Thresholds

Hearing Loss

United States
Ina-Respond
National Institute of Health Research and Development, Ministry of Health... and other collaborators

Completed

Therapeutic Study to Evaluate the Safety and Efficacy of DW-MSC in COVID-19 Patients (DW-MSC)

Covid19 | Corona Virus Infection | SAR

Indonesia
Aliona Vilinsky-Redmond

Completed

Active Warming Versus Non Active Warming During Caesarean Section for Preventing Neonatal Hypothermia (NeoHyp)

Neonatal Hypothermia

Ireland
Ina-Respond
Center for Research and Development of Health Resources and Services, National...

Recruiting

Efficacy and Safety of Favipiravir in Covid-19 Patients in Indonesia (FVR)

Covid19 | Infectious Disease | SARS-CoV Infection

Indonesia
Ina-Respond
National Institute of Allergy and Infectious Diseases (NIAID); National Institute...

Completed

The Etiology of Acute Febrile Illness Requiring Hospitalization (AFIRE)

Acute Febrile Illness

Indonesia
Redmond Fire Department Medic One
Medic One Foundation

Unknown

Randomized Trial of Prehospital Tropin Levels in Acute Coronary Syndrome (ACS)

Acute Coronary Syndrome

United States
Ina-Respond
National Institute of Health Research and Development, Ministry of Health... and other collaborators

Completed

Tuberculosis Research of INA-RESPOND On Drug Resistance (TRIPOD)

Lung Tuberculosis | MDR TB

Indonesia
Ina-Respond
National Institute of Health Research and Development, Ministry of Health... and other collaborators

Completed

Validation of POC-CCA Rapid Urine Test for Qualitative Detection of Schistosoma Japonicum (SchisCCA)

Aged ≥2 Years in Schistosomiasis Affected Areas

Indonesia
Ablon Skin Institute Research Center
Irish Response t/a Lifes2good

Completed

Viviscal Extra-Strength Formulation To Promote Hair Growth And Decrease Shedding In Women With Thinning Hair

Hair Thinning
The Immune Response Corporation

Completed

An Expanded Access Open-Label, Compassionate Use Protocol of Remune in HIV-1-Infected Adults With CD4 Count Less Than 300 Cells/Ml

HIV Infections

United States
The Immune Response Corporation

Completed

A Multicenter, Double-Blind, Phase III, Adjuvant-Controlled Study of the Effect of 10 Units of HIV-1 Immunogen (Remune) Compared to Incomplete Freund's Adjuvant (IFA) Alone Every 12 Weeks on AIDS-Free Survival in Subjects With HIV Infection and CD4 T-Lymphocytes Between 300 and 549 Cells/microL Rega

HIV Infections

United States
The Immune Response Corporation

Completed

An Expanded Access Open Label Protocol of Remune (HIV-1 Immunogen) in HIV-1-Infected Adults With CD4 Count 550 Cells /Ml and Greater.

HIV Infections

United States
University of Liverpool
Liverpool School of Tropical Medicine; Desmond Tutu Health Foundation

Recruiting

Doravirine Dose Optimisation in Pregnancy (DoraDO)

HIV

South Africa
Desmond Tutu TB Centre
University of Stellenbosch; UNITAID; Chiang Mai University

Recruiting

Pharmacokinetics and Safety of DolutegravIr in Neonate (PETITE-DTG)

Hiv

South Africa
Johns Hopkins University
Bill and Melinda Gates Foundation; Communicable Disease Program, Brazil; Consortium...

Completed

TB (Tuberculosis) Preventive Therapy for HIV Patients With Access to HAART (Highly Active Antiretroviral Therapy)

HIV Infections | Tuberculosis

Brazil
University of Pennsylvania
Bill and Melinda Gates Foundation; Desmond Tutu HIV Foundation

Completed

Effect of U=U Messaging on HIV in South Africa (U=U)

HIV/AIDS

South Africa
Ablon Skin Institute Research Center
DeNova Research; Irish Response t/a Lifes2good

Completed

Efficacy of the New Viviscal Professional Strength Oral Supplement in Females With Thinning Hair

Hair Thinning
National Institute of Allergy and Infectious Diseases...
The Immune Response Corporation

Terminated

Effectiveness of Adding Remune to Your Current Anti-HIV Drug Combination

HIV Infections

United States
Helen Reynolds
Desmond Tutu HIV Centre; Infectious Disease Institute, Kampala, Uganda

Active, not recruiting

Drug Interactions Between Dolutegravir and Escalating Doses of Rifampicin (DoRIS)

Tuberculosis | Hiv

Uganda, South Africa
University of California, Los Angeles
University of Cape Town; Desmond Tutu HIV Foundation

Completed

Evaluation of Pre-exposure Prophylaxis Cascade in Pregnant and Breastfeeding Women in Cape Town (Formative Study) (PrEP-PP)

Hiv

South Africa
ISA Associates, Inc.

Recruiting

Mobile Stress Management Program for African American Women

Psychological Stress

United States
ISA Associates, Inc.

Completed

Improving HIV Outcomes Among African American Transgender Women

HIV

United States
Rna Diagnostics Inc.

Recruiting

RNA Disruption Assay (RDA)-Breast Cancer Response Evaluation for Individualized Therapy (BREVITY)

Breast Neoplasm Female

Germany, United States, Canada, France, Italy, Spain, Poland
IND Diagnostic Inc.

Unknown

Evaluation of the IND One Step Strep A Rapid Test vs. Culture

Strep Throat

United States
University of Cape Town
Desmond Tutu HIV Centre; Wits Reproductive Health and HIV Institute

Terminated

Clinical Evaluation of Adjusted Doses of Darunavir/Ritonavir With Rifampicin in HIV-infected Volunteers (Darifi)

HIV Infections

South Africa

Clinical Trials Sponsored by Ina-Respond

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Jordan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations